The beneficial effect of oral sodium bicarbonate in peritoneal dialysis patients - How long does it last after stopping treatment?

Hong Kong Journal of Nephrology

Volumn 7, Issue 1, 2005, Pages 14-21

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Kwan, Bonnie Ching Ha ^a   Chung, Kwok Yi ^a   Leung, Chi Bon ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Continuous ambulatory peritoneal dialysis; Metabolic acidosis; Mortality; Nutritional status; Sodium bicarbonate

Indexed keywords

BICARBONATE; NITROGEN; PLACEBO; PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LONG TERM CARE; MALE; MALNUTRITION; METABOLIC ACIDOSIS; MORTALITY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL RATE; TREATMENT WITHDRAWAL;

EID: 18144392328     PISSN: 15615413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1561-5413(09)60175-7     Document Type: Article

References (34)

1. Mitch WE, Goldberg AL. Mechanisms of muscle wasting: the role of the ubiquitin-proteasome pathway. N Engl J Med 1997;335: 1897-905.
2. Mitch WE, Medina R, Greiber S, May RC, England BK, Price SR, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 1994;93:2127-33.
3. England BK, Greiber S, Mitch WE, Bowers BA, Herring WJ, McKean M, et al. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 1995;268:C1395-400.
4. Isozaki U, Mitch WE, England BK, Price SR. Protein degradation and increased mRNAs encoding proteins of the ubiquitin-proteasome proteolytic pathway in BC3H1 myocytes require interaction between glucocorticoids and acidification. Proc Natl Acad Sci USA 1996;93:1967-71.
5. Bailey JL, Wang X, England BK, Price SR, Ding X, Mitch WE. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent, ubiquitin-proteasome pathway. J Clin Invest 1996;97:1447-53.
6. Reaich D, Channon SM, Scrimgeour CM, Daley SE, Wilkinson R, Goodship THJ. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 1993; 265:E230-5.
7. Graham KA, Reaich D, Channon SM, Downie S, Goodship TH. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 1997;8:632-7.
8. Graham KA, Reaich D, Channon SM, Downie S, Gilmour E, Passlick-Deetjen J, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 1996;49:1396-400.
9. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 2002;61:1286-92.
10. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients - a randomized placebo-control trial. J Am Soc Nephrol 2003;14:2119-26.
11. Tranaeus A, Heimburger O, Lindholm B, Bergstrom J. Six years experience of CAPD at one centre: a survey of major findings. Perit Dial Int 1988;8:31-41.
12. Robson MD, Faivoseviz A, Malmoud H. Physiological transfer of acid base. In: Legrain M, ed. Continuous Ambulatory Peritoneal Dialysis. Proceedings of an International Symposium. Amsterdam: Excerpta Medica, 1980:194.
13. Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, et al. Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1992;38:M139-42.
14. Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous peritoneal dialysis. J Am Soc Nephrol 1996;7:745-8.
15. Mak TW, Cheung CK, Cheung CM, Leung CB, Lam CW, Lai KN. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997;12:184-6.
16. II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 2001;37(Suppl 1):S65-136.
17. Enia G, Sicus C, Alati G, Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993;8: 1094-8.
18. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int 1998; 18:467-73.
19. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980;33:27-39.
20. Forbes GB, Bruining GJ. Urinary creatinine excretion and lean body mass. Am J Clin Nutr 1976;29:1359-66.
21. Reaich D, Channon SM, Scrimgeour CM, Goodship THJ. Ammonium chloride-induced acidosis increases protein breakdown and amino acid oxidation in humans. Am J Physiol 1992; 263:E735-9.
22. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein catabolism in rats with chronic uraemia. J Clin Invest 1987; 79:1099-103.
23. Wing SS, Goldberg AL. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 1993;264:E668-76.
24. Kooman JP, Deutz NE, Zijlmans P, van den Wall Bake A, Gerlag PG, van Hooff JP, et al. The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in hemodialysis patients with metabolic acidosis. Nephrol Dial Transplant 1997;12:2397-401.
25. Lin SH, Lin YF, Chin HM, Wu CC. Must metabolic acidosis be associated with malnutrition in hemodialysis patients? Nephrol Dial Transplant 2002;17:2006-10.
26. Seyffart G, Ensminger A, Scholz R. Increase of body mass during long-term bicarbonate hemodialysis. Kidney Int 1987;22:S174-7.
27. Roberts RG, Gilmour ER, Goodship TH. The correction of acidosis does not increase dietary protein intake in chronic renal failure patients. Am J Kidney Dis 1996;28:350-3.
28. Movilli E, Zani R, Carli O, Sangalli L, Pola A, Camerini C, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 1998;13:1719-22.
29. Verove C, Maisonneuve N, El Azouzi A, Boldron A, Azar R. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr 2002;12:224-8.
30. Mehrotra R, Kopple JD, Wolfson M. Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int 2003;64(Suppl 88):S13-25.
31. Williams AJ, Dittmer ID, McArley A, Clarke J. High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status. Nephrol Dial Transplant 1997;12:2633-7.
32. Brady JP, Hasbargen JA. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis 1998;31:35-40.
33. Stein A, Moorhouse J, Iles-Smith H, Baker F, Johnstone J, James G, et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 1997;52:1089-95.
34. Harty J, Faragher B, Venning M, Gokal R. Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis.) Perit Dial Int 1995;15:105-9.